Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens

Weycker Derek; Li Xiaoyan; Edelsberg John; Barron Rich; Kartashov Alex; Xu Hairong; Lyman Gary H.

首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens

【24h】

Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens

机译：接受新兴化疗方案的患者出现发热性中性粒细胞减少的风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Considerable evidence exists concerning the risk of febrile neutropenia (FN) associated with well-established, older chemotherapy regimens. Little is known, however, about the risks associated with many regimens that were introduced in the past decade and have become the predominant choice for certain cohorts of patients or are increasingly being used in clinical practice.

机译：存在与成熟的较老的化疗方案相关的发热性中性粒细胞减少症（FN）风险的大量证据。然而，人们对过去十年中引入的许多方案相关的风险知之甚少，这些方案已成为某些患者群体的主要选择，或正越来越多地用于临床实践。

著录项

来源
《Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer》 |2014年第12期|共11页
作者
Weycker Derek; Li Xiaoyan; Edelsberg John; Barron Rich; Kartashov Alex; Xu Hairong; Lyman Gary H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类护理学;
关键词
Febrile neutropenia; Chemotherapy; Breast cancer; Non-Hodgkin's lymphoma; Pancreatic cancer;

机译：发热性中性粒细胞减少症;化学疗法;乳腺癌;非霍奇金淋巴瘤;胰腺癌;

相似文献

外文文献
中文文献
专利

1. Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens for breast cancer [J] . Gilbar Peter, Sorour Natacha, McPherson Ian Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2015,第3期

机译：接受新兴化疗方案的乳腺癌患者出现发热性中性粒细胞减少症的风险
2. Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens [J] . Weycker Derek, Li Xiaoyan, Edelsberg John, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2014,第12期

机译：接受新兴化疗方案的患者出现发热性中性粒细胞减少的风险
3. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors [J] . Alena M Pfeil, Christof Vulsteke, Robert Paridaens, BMC Cancer . 2014,第1期

机译：接受化疗的早期乳腺癌患者发热性中性粒细胞减少症发生的多变量回归分析，评估患者相关，化疗相关和遗传危险因素
4. The Role of Prophylactic Antibiotics on ANC Value and Fever Duration in Cancer Patients with Post-Chemotherapy Neutropenia Fever [C] . E P Yunita, G J R Subagiyo, S O Wardhani International Seminar on Smart Molecule of Natural Resources . 2020

机译：预防性抗生素对化疗后化学性中性蛋白发热后癌症患者ANC Valys and Heation的作用
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy effectiveness and safety [O] . Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, 2021

机译：预防性Pegfilgrastim以防止患者的患者患者（Q2W）化疗方案中的患者：系统审查疗效有效性和安全性
7. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors [O] . Alena M Pfeil, Christof Vulsteke, Robert Paridaens, 2014

机译：接受化疗的早期乳腺癌患者发热性中性粒细胞减少症发生的多变量回归分析，评估患者相关，化疗相关和遗传危险因素
8. Psychological Stress, Neutropenia and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer [R] . Bovbjerg, D. 1999

机译：乳腺癌化疗治疗患者的心理应激，中性粒细胞减少和传染病

Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens

摘要

著录项

相似文献

相关主题

期刊订阅